FDA — Fidia SpA Cashflow Statement
0.000.00%
Last trade - 00:00- €1.19m
- €7.88m
- €28.61m
- 21
- 82
- 11
- 27
Annual cashflow statement for Fidia SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.48 | -5.95 | -3.5 | 5.75 | -1.47 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -0.623 | -0.674 | 0.045 | -10.6 | -2.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.66 | 7.74 | 1.89 | 3.6 | -2.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.91 | 3.77 | 0.584 | 0.793 | -4.84 |
| Capital Expenditures | -0.894 | -0.499 | -0.086 | -0.298 | -0.475 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.318 | 0.029 | 0.067 | 0.118 |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.894 | -0.181 | -0.057 | -0.231 | -0.357 |
| Financing Cash Flow Items | -0.17 | 0.036 | -0.182 | 1.44 | 0.127 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -4.17 | -1.47 | -1.09 | 0.747 | 3.43 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.01 | 1.6 | 0.384 | 1.69 | -1.96 |